Novartis Transplant Drug Certican Delayed by FDA (Update1) Novartis AG, Switzerland #39;s largest drugmaker, said the US Food and Drug Administration has delayed approval of its Certican transplant treatment and is seeking more information on safe and effective dosing. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 